Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Syndax Pharmaceuticals (SNDX) Long-Term Debt Issuances (2020)

Syndax Pharmaceuticals (SNDX) has 1 years of Long-Term Debt Issuances data on record, last reported at $19.7 million in Q1 2020.

  • For Q1 2020, Long-Term Debt Issuances changed N/A year-over-year to $19.7 million; the TTM value through Dec 2020 reached $19.7 million, changed N/A, while the annual FY2020 figure was $19.7 million, N/A changed from the prior year.
  • Long-Term Debt Issuances reached $19.7 million in Q1 2020 per SNDX's latest filing.
  • Across five years, Long-Term Debt Issuances topped out at $19.7 million in Q1 2020 and bottomed at $19.7 million in Q1 2020.